Breaking News Instant updates and real-time market news.

RHI

Robert Half

$63.78

-2.58 (-3.89%)

09:36
03/25/19
03/25
09:36
03/25/19
09:36

Robert Half mentioned cautiously at Off Wall Street

RHI Robert Half
$63.78

-2.58 (-3.89%)

01/03/19
01/03/19
DOWNGRADE
Target $63

Neutral
Robert Half downgraded to Neutral on cyclical concerns at BofA/Merrill
As previously reported, BofA/Merrill analyst Gary Bisbee downgraded Robert Half to Neutral from Buy as he believes cyclical concerns and tougher comps will make it difficult for the stock to outperform in the near-term. While the analyst expects the company to deliver solid growth in 2019 if the U.S. economy grows 2% or better, revenue growth is likely to decelerate in the next few quarters as Robert Half faces sharply more difficult comps. Bisbee also believes that valuation is likely to remain depressed amid cyclical growth concerns and the length of the cycle. Additionally, the analyst lowered his price target on the shares to $63 from $75.
01/16/19
NOMU
01/16/19
NO CHANGE
Target $80
NOMU
Neutral
Robert Half price target lowered to $80 from $86 at Nomura Instinet
Nomura Instinet analyst Dan Dolev lowered his price target for Robert Half International to $80 ahead of the company's Q4 results and keeps a Buy rating on the shares. The analyst's analysis indicates that Robert Half's temporary placement same-day, constant-currency growth could be 8% in Q4, resulting in 9% overall growth, "only slightly" above the midpoint of the guidance range and roughly in line with consensus estimates.
01/23/19
NRCS
01/23/19
NO CHANGE
Target $45
NRCS
Sell
Robert Half price 'too high', Kelly Services 'attractive', says Northcoast
Northcoast analyst John Healy is keeping his Sell rating and $45 price target on Robert Half (RHI) as part of his broader research note on staffing companies, saying that while business activity in Q4 was in growth mode with a 5.2% reported rate of increase, he sees its stock price as too high. Healy adds that Robert Half's longer term competitive dynamics and margin profile are concerning. The analyst has a positive view on Kelly Services (KELYA) from a risk-reward perspective however, keeping his Buy rating and $31 price target on the shares, as he sees the stock price trading below its intrinsic value.
01/30/19
RHCO
01/30/19
NO CHANGE
Target $70
RHCO
Hold
Robert Half price target lowered to $70 from $76 at SunTrust
SunTrust analyst Tobey Sommer lowered his price target on Robert Half to $70 after its Q4 results, saying that while the company generated higher margins and matched strong consulting demand with higher staff count of its own, he remains concerned by the revenue impact from the slowing macro data in Europe. The analyst kept his Hold rating on Robert Half, even though he is "intrigued by the company's cross-selling consulting and staffing services as a significant potential long-term driver of growth." Sommer also raised his FY19 EPS outlook by 6c to $4.00, adding that the ROIC for Q4 was a standout and "reflects the long term organic growth story" at Robert Half.

TODAY'S FREE FLY STORIES

DXC

DXC Technology

$56.32

-1.35 (-2.34%)

07:25
05/20/19
05/20
07:25
05/20/19
07:25
Recommendations
DXC Technology analyst commentary  »

DXC Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

REGN

Regeneron

$304.81

-4.69 (-1.52%)

07:24
05/20/19
05/20
07:24
05/20/19
07:24
Recommendations
Regeneron analyst commentary  »

Barclays still bearish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 14

    Jun

  • 26

    Jun

BYND

Beyond Meat

07:23
05/20/19
05/20
07:23
05/20/19
07:23
Initiation
Beyond Meat initiated  »

Beyond Meat initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$147.06

-1.63 (-1.10%)

07:23
05/20/19
05/20
07:23
05/20/19
07:23
Downgrade
Clorox rating change  »

Clorox downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

07:22
05/20/19
05/20
07:22
05/20/19
07:22
Downgrade
Bristol-Myers rating change  »

Bristol-Myers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 29

    May

  • 31

    May

SPN

Superior Energy

$2.49

-0.24 (-8.79%)

07:20
05/20/19
05/20
07:20
05/20/19
07:20
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

07:20
05/20/19
05/20
07:20
05/20/19
07:20
General news
FX Update: The dollar has put a mixed performance »

FX Update: The dollar has…

MTSC

MTS Systems

$56.33

-0.13 (-0.23%)

07:18
05/20/19
05/20
07:18
05/20/19
07:18
Recommendations
MTS Systems analyst commentary  »

MTS Systems price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTS

Akoustis

$7.39

-0.62 (-7.74%)

07:17
05/20/19
05/20
07:17
05/20/19
07:17
Hot Stocks
Akoustis announces shipments, production order for 3.8GHz filters »

Akoustis announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

AZN

AstraZeneca

$37.80

0.02 (0.05%)

07:16
05/20/19
05/20
07:16
05/20/19
07:16
Hot Stocks
AstraZeneca reports data from Novel START trial of Symbicort »

New data from Novel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

DE

Deere

$134.82

-11.15 (-7.64%)

07:15
05/20/19
05/20
07:15
05/20/19
07:15
Recommendations
Deere analyst commentary  »

Deere price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

PDCE

PDC Energy

$36.67

-0.55 (-1.48%)

07:13
05/20/19
05/20
07:13
05/20/19
07:13
Hot Stocks
PDC Energy CEO sends letter to shareholders, encourages white proxy card vote »

PDC Energy mailed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

HEI

Heico

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Heico analyst commentary  »

Heico price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 05

    Jun

MU

Micron

$36.06

-1.37 (-3.66%)

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Micron analyst commentary  »

Micron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CLI

Mack-Cali Realty

$22.92

-0.12 (-0.52%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Hot Stocks
Mack-Cali Realty recommends stockholders vote the WHITE proxy card »

Mack-Cali strongly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

07:10
05/20/19
05/20
07:10
05/20/19
07:10
General news
Oil prices down from highs over USD 63 »

Oil prices down from…

ZAYO

Zayo Group

$32.70

-0.09 (-0.27%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Downgrade
Zayo Group rating change  »

Zayo Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TSLA

Tesla

$211.02

-17.56 (-7.68%)

07:09
05/20/19
05/20
07:09
05/20/19
07:09
Recommendations
Tesla analyst commentary  »

Tesla price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

, MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

07:08
05/20/19
05/20
07:08
05/20/19
07:08
Recommendations
Alnylam, The Medicines Co. analyst commentary  »

Alnylam partner presented…

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

SPTN

SpartanNash

$14.94

-0.27 (-1.78%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Earnings
SpartanNash reaffirms FY19 adjusted EPS view $1.20-$1.50, consensus $1.69 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 22

    May

CGEN

Compugen

$3.45

0.01 (0.29%)

, BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Hot Stocks
Compugen doses first patient in Phase 1 COM701/Opdivo study »

Compugen (CGEN) announced…

CGEN

Compugen

$3.45

0.01 (0.29%)

BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 20

    May

  • 29

    May

  • 31

    May

TRK

Speedway Motorsports

$18.14

-0.035 (-0.19%)

07:06
05/20/19
05/20
07:06
05/20/19
07:06
Hot Stocks
Speedway Motorsports retains advisor to consider going private proposal »

Speedway Motorsports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$104.76

-2.98 (-2.77%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Recommendations
Xilinx analyst commentary at Nomura Instinet »

U.S. action against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$5.29

-0.07 (-1.31%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Hot Stocks
Intec Pharma granted European patent »

Intec Pharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:05
05/20/19
05/20
07:05
05/20/19
07:05
General news
Tech sector weighs on global stock markets »

Tech sector weighs on…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.